Intranasal vaccination with a Newcastle disease virus-vectored vaccine protects hamsters from SARS-CoV-2 infection and disease

The pandemic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of coronavirus disease 2019 (COVID-19). Worldwide efforts are being made to develop vaccines to mitigate this pandemic. We engineered two recombinant Newcastle disease virus (NDV) vectors expressing either the ful...

Descripción completa

Detalles Bibliográficos
Autores principales: Warner, Bryce M., Santry, Lisa A., Leacy, Alexander, Chan, Mable, Pham, Phuc H., Vendramelli, Robert, Pei, Yanlong, Tailor, Nikesh, Valcourt, Emelissa, Leung, Anders, He, Shihua, Griffin, Bryan D., Audet, Jonathan, Willman, Marnie, Tierney, Kevin, Albietz, Alixandra, Frost, Kathy L., Yates, Jacob G.E., Mould, Robert C., Chan, Lily, Mehrani, Yeganeh, Knapp, Jason P., Minott, Jessica A., Banadyga, Logan, Safronetz, David, Wood, Heidi, Booth, Stephanie, Major, Pierre P., Bridle, Byram W., Susta, Leonardo, Kobasa, Darwyn, Wootton, Sarah K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492382/
https://www.ncbi.nlm.nih.gov/pubmed/34632328
http://dx.doi.org/10.1016/j.isci.2021.103219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492382/
https://www.ncbi.nlm.nih.gov/pubmed/34632328
http://dx.doi.org/10.1016/j.isci.2021.103219

Ejemplares similares